Type 1 Diabetes – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Type 1 Diabetes Market Outlook Thelansis’s “Type 1 Diabetes Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Type 1 Diabetes treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Type 1 Diabetes Overview Type 1 diabetes has traditionally been diagnosed based on clinical catabolic symptoms suggestive of insulin deficiency: polyuria, polydipsia, weight loss, and marked hyperglycemia that is non-responsive to oral agents. It is categorized as an autoimmune disease with progressive B-cell destruction, resulting in a physiological dependence on exogenous insulin. Recent studies have broadened our understanding of the disease, but ...